Early amyloid pathology in mice synergistically worsens post-sepsis behavioral impairment and microglial synaptic

Kate A Giffin1, Niyati Puranik2, Angela C Bustamante3

  • 1Neuroscience Graduate Program, University of Michigan, Ann Arbor, MI, USA.

Insights

Early amyloid pathology worsens sepsis-induced cognitive decline and neuroinflammation. This study in 5xFAD mice reveals amyloid exacerbates sepsis effects on the brain, highlighting a potential risk factor for long-term sepsis complications.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Sepsis survivors face lasting cognitive and mental health issues.
  • Mechanisms and vulnerability factors for post-sepsis brain dysfunction remain unclear.
  • Amyloid pathology, a neuroinflammatory process, is a potential latent risk factor.

Purpose of the Study:

  • To investigate if early amyloid pathology exacerbates sepsis-induced neuroinflammation and cognitive impairment.
  • To explore the role of microglial dysfunction and complement pathways in post-sepsis brain changes.

Main Methods:

  • Sepsis was induced using cecal ligation and puncture (CLP) in young adult 5xFAD mice modeling early amyloid pathology.
  • Cognitive function was assessed using fear conditioning and puzzle box tasks.
  • Brain transcriptomics, gene expression, and microglial synaptic phagocytosis were analyzed.

Main Results:

  • 5xFAD CLP mice showed impaired cognition and heightened neuroinflammatory pathways post-sepsis.
  • Complement gene expression (C3, C3aR) was elevated in 5xFAD CLP survivors.
  • Increased microglial synaptic phagocytosis was observed in 5xFAD CLP survivors.

Conclusions:

  • Early amyloid pathology synergistically amplifies sepsis-induced behavioral changes and neuroinflammation.
  • Amyloid pathology may heighten microglial synaptic phagocytosis, contributing to brain dysfunction after sepsis.
  • Amyloid pathology represents a significant risk factor for exacerbated post-sepsis cognitive decline.

Related Concept Videos